Patents by Inventor Peter O'Connell

Peter O'Connell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230061947
    Abstract: Systems, methods, and apparatuses for implementing a behavioral responsive adaptive context engine for emotionally-responsive experiences are disclosed.
    Type: Application
    Filed: August 27, 2021
    Publication date: March 2, 2023
    Inventors: Frank Caron, Peter O'Connell, Daniel Thomas Harrison, Arastun Efendiyev
  • Patent number: 7429650
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: September 30, 2008
    Assignee: Baylor College of Medicine
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Patent number: 7419785
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: July 21, 2004
    Date of Patent: September 2, 2008
    Assignee: Baylor College of Medicine
    Inventors: Suzanne Fuqua, D. Craig Allred, Peter O'Connell, Torsten A. Hopp
  • Patent number: 7388868
    Abstract: Emergency call-routing apparatus, and an associated method, for use in a packet-based, telephonic network. An emergency call router is positioned selectably to provide local call handling functionality to a local network that is normally connected by way of an access gateway to the telephonic network whose operation is normally controlled by a softswitch. The apparatus is used when, e.g., a total communication link failure condition occurs between the access gateway and the softswitch. The emergency call router selectably routes calls within the local network to permit continued, local calling functionality in spite of the failure of the communication link. High-priority calls, such as calls placed to an emergency dispatch center, are routed within the local network to a designated, local-network station. And local calls are also selectably routed by the emergency call router. A call priority scheme is also used in the event that call capacity is exceeded.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: June 17, 2008
    Assignee: Alcatel Lucent
    Inventors: Peter O'Connell, John Abraira, Gary Hanson, Xing Chen, Babu Mani
  • Publication number: 20050176072
    Abstract: The present invention is directed to providing a prognosis of disease—free survival for a cancer patient. The invention further relates to methods of prognosticating recurrence or metastasis by determining a level of an MTA1 polypeptide in the patient. Yet further, the methods allow for prognosticating and/or predicting micrometastasis in a patient and offer the improvement in the efficacy of clinical treatment of the patient.
    Type: Application
    Filed: June 20, 2003
    Publication date: August 11, 2005
    Inventors: Michelle Martin, Peter O'Connell, D. Allred, Gary Clark
  • Publication number: 20040265895
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: July 21, 2004
    Publication date: December 30, 2004
    Inventors: Suzanne Fuqua, D. Craig Allred, Peter O'Connell, Torsten A. Hopp
  • Patent number: 6821732
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: November 23, 2004
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Publication number: 20040018527
    Abstract: The invention pertains to differential gene expression profiles for docetaxel responsiveness. The invention identifies molecular profiles in primary breast cancers that appear to predict response or lack of response to docetaxel. This invention provides methods involving prediction of docetaxel responsiveness as well as arrays for use in determining docetaxel responsivness.
    Type: Application
    Filed: May 16, 2003
    Publication date: January 29, 2004
    Inventors: Jenny C. Chang, Peter O'Connell
  • Publication number: 20030186313
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: May 13, 2003
    Publication date: October 2, 2003
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Publication number: 20030027778
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 6, 2003
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp
  • Patent number: 5743646
    Abstract: A temperature sensor comprising: a hollow tube with a first end and a second end, wherein the second end is closed sealing a cavity within the tube from an environment outside of the tube and wherein the first end has an exterior cylindrical surface; a temperature responsive sensing element within the tube proximate to the second end; a glass cylinder having an inner cylindrical surface in sealing engagement with the exterior cylindrical surface of the first end of the tube; and a sensor housing having an inner cylindrical cavity bounded by an inner cylindrical wall, wherein an outer cylindrical surface of the glass cylinder is sealingly engaged with the inner cylindrical wall.
    Type: Grant
    Filed: July 1, 1996
    Date of Patent: April 28, 1998
    Assignee: General Motors Corporation
    Inventors: David Peter O'Connell, Randall Christian Sumner
  • Patent number: 5678555
    Abstract: A method for locating blood vessels in a live human body utilizing infrared scanning and imaging techniques to distinguish relative temperature differences between blood carrying vessels and surrounding human tissue. An infrared imaging camera is used to detect the emissions of an object to differentiate the specific elevated surface temperature associated with blood vessels in a human body and surrounding tissue and marking same by the introduction of a marking device visible through temperature differentiation within the infrared imaging field.
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: October 21, 1997
    Inventor: Peter O'Connell
  • Patent number: 5411859
    Abstract: The present invention is related to the identification of cloned DNA sequences that reveal individual multiallele loci. The loci are used in the process of the present invention to provide convenient and accurate genetic identification. A large number of clones that recognize VNTR loci have been isolated from a cosmid library and characterized.
    Type: Grant
    Filed: June 10, 1991
    Date of Patent: May 2, 1995
    Assignee: University of Utah Research Foundation
    Inventors: Raymond L. White, Yusuke Nakamura, Peter O'Connell, Midvale, Mark F. Leppert
  • Patent number: 5227292
    Abstract: The present invention relates to the neurofibromatosis type 1 (NF1) gene and its gene product. The invention further relates to methods for the detection in and treatment of humans having defective NF1 genes and for detection of tumors caused by a defective NF1 gene.
    Type: Grant
    Filed: July 12, 1990
    Date of Patent: July 13, 1993
    Assignee: University of Utah
    Inventors: Raymond L. White, Peter O'Connell, David H. Viskochil, Richard M. Cawthon
  • Patent number: 4963663
    Abstract: The present invention is related to the identification of cloned DNA sequences that reveal individual multiallele loci. The loci are used in the process of the present invention to provide convenient and accurate genetic identification. A large number of clones that recognize VNTR loci have been isolated from a cosmid library and characterized.
    Type: Grant
    Filed: February 8, 1989
    Date of Patent: October 16, 1990
    Assignee: University of Utah
    Inventors: Raymond L. White, Yusuke Nakamura, Peter O'Connell, Mark F. Leppert
  • Patent number: 4539210
    Abstract: A structured meat product which may resemble a natural cut of meat comprises a lean portion formed by extrusion of multiple lean meat chunks bonded by a protein exudate and a fat cap or rim formed by simultaneous extrusion of a fat emulsion. The product is made by preparing chunks of lean meat substantially free of fat, gristle and sinew. The muscle scaffold network is slackened e.g., by multiple severing of the connective tissue of the lean meat chunks. These chunks then are massaged under reduced pressure to produce the protein exudate, while sufficient water is added to obtain a desired protein-to-moisture ratio. Fat trimmings are ground and blended into an emulsion which is simultaneously extruded with the lean meat chunks through separate but adjacent extrusion heads which may be shaped to produce a product resembling a steak, roast or other conventional cut of natural meat.
    Type: Grant
    Filed: August 7, 1978
    Date of Patent: September 3, 1985
    Assignee: Peter M. O'Connell
    Inventors: Peter O'Connell, Michael A. Gibbs
  • Patent number: 4027582
    Abstract: A drip coffee maker which makes an aqueous infusion which has a water inlet control means for controlling the entry of water into a brewing chamber from an upper hot water chamber.
    Type: Grant
    Filed: January 19, 1976
    Date of Patent: June 7, 1977
    Inventor: Gerard Peter O'Connell